San Diego, CA 12/23/08—Volcano, a publicly held medical device company, has agreed to acquire Axsun Technologies for $21.5 million in cash. Axsun develops and manufactures MEMS-based lasers and optical engines for optical coherence tomography (OCT) imaging systems, micro-optical spectrometers and optical channel monitors for pharmaceutical, chemical, petrochemical and telecommunication network applications. Axsun posted 2007 sales […]
Company Announcements Organic revenues for Merck KGaA’s Life Science Solutions business increased 13% in the second quarter and 8.0% in the third quarter. Sigma-Aldrich exclusively licensed boronic acid surrogates for use in Suzuki-Miyaura coupling from the University of Illinois at Urbana-Champaign and will offer MIDA synthons for sale. The technology enables the efficient construction of […]
R&D spending in Singapore increased 26.5% to SGD 6,339 million ($4,370 million), or 2.61% of GDP, according to a survey by the Agency for Science, Technology and Research (A*STAR). Experimental development, applied research and basic research accounted for 58%, 25% and 17% of R&D expenditures, respectively. Engineering and technology represented 65% of R&D expenditures, while […]
Company Announcements Alpha Innotech extended its OEM agreement with GE Healthcare, signing a five-year strategic supplier alliance agreement. GWC Technologies appointed Cybeles Life Science as a distributor for Southeast Asia. ForteBio closed $25 million in Series C financing, led by OrbiMed Advisors, in September. Integrated DNA Technologies entered into an exclusive copromotional agreement with 454 […]
Austria’s transformation of its R&D system over the last decade has attracted the attention of France, Spain and the Czech Republic, which are each following Austria’s model in hopes of attracting new R&D investments. This year, the country’s R&D spending as a percentage of GDP is expected to be 2.68%, compared to 1.8% 10 years […]
A meeting of the FDA’s Oncologic Drugs Advisory Committee earlier this month discussed the use of retrospective biomarker data in making regulatory decisions. Amgen and ImClone are seeking approval to include such data on drug labels. Amgen’s Vectibix and ImClone’s Erbitux are monoclonal antibodies used to treat colon cancer. Amgen is also seeking approval of […]
Carlsbad, CA and Abbott Park, IL 12/17/08—Isis Pharmaceuticals announced that Abbott has exercised its option to acquire the remaining equity ownership of Isis’s Ibis Biosciences subsidiary for $175 million and earn-out payments. Bayer currently owns 18.6% of Ibis, for which the company paid $40 million (see IBO 2/15/08, 10/31/08). Ibis’s T5000 Biosensor System identifies and […]
According to Battelle and R&D Magazine, R&D spending worldwide will increase by approximately 3.2% next year to $1,140 billion, excluding inflation. US R&D spending is estimated to increase 1.75% to $383.5 billion, excluding inflation. Including the effects of inflation, US R&D spending is forecasted to decline 1.6%, as federal government funding falls 1.9% and industrial […]
This year will be a period most investors would soon rather forget, as virtually all international stock markets suffered significant losses due to the current global economic crisis. For the year, the Dow Jones World Index fell approximately 43%, despite international efforts to lower interest rates and increase spending through massive bailout plans. The credit […]
A new survey by KPMG and the Semiconductor Industry Association finds that semiconductor companies do not expect an industry recovery any time soon. The November survey interviewed 85 senior executives at device, foundry and fabless companies. Fifty-two percent of the executives expect revenues to decrease and 69% expect profitability to decline over the next year […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
